pubmed-article:18468337 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18468337 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
pubmed-article:18468337 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
pubmed-article:18468337 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
pubmed-article:18468337 | lifeskim:mentions | umls-concept:C0332305 | lld:lifeskim |
pubmed-article:18468337 | lifeskim:mentions | umls-concept:C0205276 | lld:lifeskim |
pubmed-article:18468337 | lifeskim:mentions | umls-concept:C1514474 | lld:lifeskim |
pubmed-article:18468337 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
pubmed-article:18468337 | lifeskim:mentions | umls-concept:C0024485 | lld:lifeskim |
pubmed-article:18468337 | lifeskim:mentions | umls-concept:C1450294 | lld:lifeskim |
pubmed-article:18468337 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
pubmed-article:18468337 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
pubmed-article:18468337 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:18468337 | pubmed:dateCreated | 2008-5-12 | lld:pubmed |
pubmed-article:18468337 | pubmed:abstractText | To determine retrospectively the role of endorectal magnetic resonance in the staging of prostate cancer. The aim of the study was to assess whether it is possible to identify a group of patients with prostate cancer, chosen for certain prognostic factors, eligible for radiotherapy that could take advantage of endorectal magnetic resonance in staging and therapy management. | lld:pubmed |
pubmed-article:18468337 | pubmed:language | eng | lld:pubmed |
pubmed-article:18468337 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18468337 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18468337 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18468337 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18468337 | pubmed:issn | 0300-8916 | lld:pubmed |
pubmed-article:18468337 | pubmed:author | pubmed-author:StasiMicheleM | lld:pubmed |
pubmed-article:18468337 | pubmed:author | pubmed-author:AgliettaMassi... | lld:pubmed |
pubmed-article:18468337 | pubmed:author | pubmed-author:ReggeDanieleD | lld:pubmed |
pubmed-article:18468337 | pubmed:author | pubmed-author:GabrielePietr... | lld:pubmed |
pubmed-article:18468337 | pubmed:author | pubmed-author:MalinverniGiu... | lld:pubmed |
pubmed-article:18468337 | pubmed:author | pubmed-author:CirilloStefan... | lld:pubmed |
pubmed-article:18468337 | pubmed:author | pubmed-author:VormolaRobert... | lld:pubmed |
pubmed-article:18468337 | pubmed:author | pubmed-author:OrtegaCinziaC | lld:pubmed |
pubmed-article:18468337 | pubmed:author | pubmed-author:BonaCristina... | lld:pubmed |
pubmed-article:18468337 | pubmed:author | pubmed-author:PetracchiniMa... | lld:pubmed |
pubmed-article:18468337 | pubmed:author | pubmed-author:DurandoSabina... | lld:pubmed |
pubmed-article:18468337 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:18468337 | pubmed:volume | 94 | lld:pubmed |
pubmed-article:18468337 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18468337 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18468337 | pubmed:pagination | 65-9 | lld:pubmed |
pubmed-article:18468337 | pubmed:dateRevised | 2008-12-12 | lld:pubmed |
pubmed-article:18468337 | pubmed:meshHeading | pubmed-meshheading:18468337... | lld:pubmed |
pubmed-article:18468337 | pubmed:meshHeading | pubmed-meshheading:18468337... | lld:pubmed |
pubmed-article:18468337 | pubmed:meshHeading | pubmed-meshheading:18468337... | lld:pubmed |
pubmed-article:18468337 | pubmed:meshHeading | pubmed-meshheading:18468337... | lld:pubmed |
pubmed-article:18468337 | pubmed:meshHeading | pubmed-meshheading:18468337... | lld:pubmed |
pubmed-article:18468337 | pubmed:meshHeading | pubmed-meshheading:18468337... | lld:pubmed |
pubmed-article:18468337 | pubmed:meshHeading | pubmed-meshheading:18468337... | lld:pubmed |
pubmed-article:18468337 | pubmed:meshHeading | pubmed-meshheading:18468337... | lld:pubmed |
pubmed-article:18468337 | pubmed:meshHeading | pubmed-meshheading:18468337... | lld:pubmed |
pubmed-article:18468337 | pubmed:meshHeading | pubmed-meshheading:18468337... | lld:pubmed |
pubmed-article:18468337 | pubmed:meshHeading | pubmed-meshheading:18468337... | lld:pubmed |
pubmed-article:18468337 | pubmed:meshHeading | pubmed-meshheading:18468337... | lld:pubmed |
pubmed-article:18468337 | pubmed:meshHeading | pubmed-meshheading:18468337... | lld:pubmed |
pubmed-article:18468337 | pubmed:meshHeading | pubmed-meshheading:18468337... | lld:pubmed |
pubmed-article:18468337 | pubmed:articleTitle | Comparison of endorectal magnetic resonance imaging, clinical prognostic factors and nomograms in the local staging of prostate cancer patients treated with radiotherapy. | lld:pubmed |
pubmed-article:18468337 | pubmed:affiliation | Unit of Radiology, Institute for Cancer Research and Treatment IRCC, Candiolo, Turin, Italy. | lld:pubmed |
pubmed-article:18468337 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18468337 | pubmed:publicationType | Comparative Study | lld:pubmed |